Michael Dougan
MD, PhD
Assistant Professor of Medicine
👥Biography 个人简介
Michael Dougan is a gastroenterologist and immunologist at Massachusetts General Hospital who specializes in immune-mediated colitis from checkpoint inhibitors. He has characterized the pathophysiology of checkpoint inhibitor-induced colitis and evaluated vedolizumab and infliximab as steroid-sparing therapies. His laboratory work links gut microbiome composition to colitis risk and severity.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Michael Dougan 的研究动态
Follow Michael Dougan's research updates
留下邮箱，当我们发布与 Michael Dougan（Massachusetts General Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment